CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-01 | RAY DEBANJAN Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −3,000 | 10,220 | ||
| 2018-11-01 | McCarthy Sean A. President and CEO | Option exercise | +5,370 | $1.57 | $8K | 87,433 |
| 2018-11-01 | McCarthy Sean A. President and CEO | Sale | −100 | $15.01 | $2K | 87,333 |
| 2018-11-01 | McCarthy Sean A. President and CEO | Sale | −5,270 | $15.00 | $79K | 82,063 |
| 2018-11-01 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −5,370 | 137,227 | ||
| 2018-10-01 | RAY DEBANJAN Chief Financial Officer | Option exercise | +3,000 | $1.45 | $4K | 8,928 |
| 2018-10-01 | RAY DEBANJAN Chief Financial Officer | Sale | −3,000 | $18.46 | $55K | 5,928 |
| 2018-10-01 | RAY DEBANJAN Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −3,000 | 13,220 | ||
| 2018-09-04 | RAY DEBANJAN Chief Financial Officer | Option exercise | +3,000 | $1.45 | $4K | 8,928 |
| 2018-09-04 | RAY DEBANJAN Chief Financial Officer | Sale | −3,000 | $22.39 | $67K | 5,928 |
| 2018-09-04 | RAY DEBANJAN Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | +3,000 | 16,220 | ||
| 2018-09-04 | McCarthy Sean A. President and CEO | Option exercise | +13,052 | $1.57 | $21K | 95,115 |
| 2018-09-04 | McCarthy Sean A. President and CEO | Sale | −13,052 | $21.86 | $285K | 82,063 |
| 2018-09-04 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | +13,052 | 142,597 | ||
| 2018-08-01 | RAY DEBANJAN Chief Financial Officer | Option exercise | +2,710 | $1.26 | $3K | 8,638 |
| 2018-08-01 | RAY DEBANJAN Chief Financial Officer | Option exercise | +290 | $1.45 | $420 | 8,928 |
| 2018-08-01 | RAY DEBANJAN Chief Financial Officer | Sale | −3,000 | $26.05 | $78K | 5,928 |
| 2018-08-01 | RAY DEBANJAN Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | +2,710 | 0 | ||
| 2018-08-01 | RAY DEBANJAN Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | +290 | 19,220 | ||
| 2018-07-05 | McCarthy Sean A. President and CEO | Option exercise | +4,497 | $1.57 | $7K | 86,560 |
Page 17 of 33 · 649 trades